Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes

Journal of the American College of Cardiology

Volumn 46, Issue 1, 2005, Pages 29-38

  Wong, Cheuk Kit ^a,b   French, John K ^a   Aylward, Philip E G ^c   Stewart, Ralph A H ^a   Gao, Wanzhen ^a   Armstrong, Paul W ^d   Van De Werf, Frans J J ^e   Simes, R John ^f   Raffel, O Christopher ^a   Granger, Christopher B ^g   Califf, Robert M ^g   White, Harvey D ^a,h  

^a GREEN LANE HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f UNIVERSITY OF SYDNEY   (Australia)

^g DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRULOG; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PULSE RATE; SEX RATIO; ST SEGMENT DEPRESSION; SYSTOLIC BLOOD PRESSURE; THORAX PAIN;

AGED; ANGINA PECTORIS; ANTICOAGULANTS; BUNDLE-BRANCH BLOCK; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; STREPTOKINASE; SURVIVAL RATE; TIME FACTORS;

EID: 21344457033     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.02.084     Document Type: Article

References (17)

1. E.M. Antman, D.T. Anbe, P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation 110 2004 588 636
2. F. Van de Werf, D. Ardissino, A. Betriu Management of acute myocardial infarction in patients presenting with ST-segment elevation the Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 24 2003 28 66
3. L. Schamroth Myocardial infarction associated with left bundle branch block L. Schamroth The 12-Lead Electrocardiogram 1989 Blackwell Scientific Cambridge, MA 193 201
4. E.B. Sgarbossa, S.L. Pinski, A. Barbagelata Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block N Engl J Med 334 1996 481 487
5. M.C. Kontos, R.H. McQueen, R.L. Jesse, J.L. Tatum, J.P. Ornato Can myocardial infarction be rapidly identified in emergency department patients who have left bundle-branch block? Ann Emerg Med 37 2001 431 438
6. L.J. Gula, A. Dick, D. Massel Diagnosing acute myocardial infarction in the setting of left bundle branch block prevalence and observer variability from a large community study Coron Artery Dis 14 2003 387 393
7. The Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction the HERO-2 randomised trial Lancet 358 2001 1855 1863
8. R.M. Califf, L.H. Woodlief, F.E. Harrell Jr. Selection of thrombolytic therapy for individual patients development of a clinical model Am Heart J 133 1997 630 639
9. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Investigators Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet i 1986 397 402
10. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 Lancet ii 1988 349 360
11. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
12. H.D. White, F.J.J. Van de Werf Thrombolysis for acute myocardial infarction Circulation 97 1998 1632 1646
13. L.K. Newby, A.B. Storrow, W.B. Gibler Bedside multimarker testing for risk stratification in chest pain units the Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) study Circulation 103 2001 1832 1837
14. F. Okamoto, K. Sohmiya, Y. Ohkaru Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB Clin Chem Lab Med 38 2000 231 238
15. K.S. Stark, M.W. Krucoff, B. Schryver, K.M. Kent Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block Am J Cardiol 67 1991 1219 1222
16. A. Cannon, S.B. Freedman, B.P. Bailey, L. Bernstein ST-segment changes during transmural myocardial ischemia in chronic left bundle branch block Am J Cardiol 64 1989 1216 1217
17. E.B. Sgarbossa, S.L. Pinski, E.J. Topol Acute myocardial infarction and complete bundle branch block at hospital admission clinical characteristics and outcome in the thrombolytic era J Am Coll Cardiol 31 1998 105 110